Founded on the strong association between glutamatergic neurotransmission, the PV+- and SST+-interneurons' role in gamma- and theta-oscillogenesis, the NMDAR functioning, and the need for glutamatergic biomarkers, this study aims to establish a translational link between evidence from preclinical studies and findings from studies investigating patients with schizophrenia. This evidence concerns the gene SST and schizophrenia.